Skip to main content
Equibles
NOVTU logo

NOVTU · Novanta Inc · Investor Relations

Track NOVTU — free

Use NOVTU with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NOVTU.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$59.80 +1.60 (+2.75%)
S&P 400 member Russell 2000 member Rebalance outlook locked
Market Cap
$5.13B
Shares
37.82M
Volume · Oct 21 3511 Avg daily vol (3M) 37.59K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-07-27 Novanta Completes Acquisition of Riverpoint Medical
2026-07-14 Novanta Inc. Announces Schedule of Second Quarter 2026 Earnings Release and Conference Call
2026-06-22 Novanta to Present at the CJS Securities 26th Annual New Ideas Summer Conference on Thursday, July 9, 2026
2026-06-09 Novanta Inc. Announces $300 Million Private Placement
2026-06-09 Novanta Inc. Announces Acquisition of Riverpoint Medical
2026-05-15 Novanta to Present at Jefferies Global Healthcare Conference on Thursday, June 4, 2026
2026-05-15 Novanta to Present at Baird 2026 Global Consumer, Technology & Services Conference on Wednesday, June 3, 2026
2026-05-13 Novanta to Present at the William Blair 46th Annual Growth Stock Conference on Tuesday, June 2, 2026
2026-05-11 Novanta Announces Financial Results for the First Quarter 2026
2026-04-14 Novanta Inc. Announces Schedule of First Quarter 2026 Earnings Release and Conference Call
2026-03-16 Novanta Joins NVIDIA Halos AI Systems Inspection Lab
2026-02-23 Novanta Announces Financial Results for the Fourth Quarter and Full Year 2025
2026-01-22 Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, February 24, 2026

Past events

Date Event Type
2026-08-06 Novanta Inc. Announces Schedule of Second Quarter 2026 Earnings Release and Conference Call Earnings call
2026-06-09 Announcement of Riverpoint Medical acquisition Event
2026-06-04 Jefferies Global Healthcare Conference Conference
2026-06-03 Baird 2026 Global Consumer, Technology & Services Conference Conference
2026-06-02 William Blair 46th Annual Growth Stock Conference Conference
2026-05-12 Novanta, Inc. 2026 Q1 Earnings Call Earnings call
2026-02-24 Novanta, Inc. 2025 Q4 Earnings Call Earnings call
2026-01-14 J.P. Morgan 44th Annual Healthcare Conference Conference
2026-01-14 CJS Securities 26th Annual New Ideas for the New Year Investor Conference Conference
2025-11-18 Jefferies Global Healthcare Conference Conference
2025-11-11 Baird 2025 Global Industrial Conference Conference
2025-11-04 Novanta, Inc. 2025 Q3 Earnings Call Earnings call
2025-10-28 Jefferies Global Healthcare Conference Conference
2025-10-27 Novanta Hosts ISO event for Humanoid Robot Safety Standards Event
2025-09-09 Baird 2025 Global Healthcare Conference Conference
2025-08-05 Novanta, Inc. 2025 Q2 Earnings Call Earnings call
2025-07-10 CJS Securities 25th Annual New Ideas Summer Conference Conference
2025-06-04 Baird 2025 Global Consumer, Technology & Services Conference Conference
2025-06-03 William Blair 45th Annual Growth Stock Conference Conference
2025-05-06 Novanta, Inc. 2025 Q1 Earnings Call Earnings call
2025-02-25 Novanta, Inc. 2024 Q4 Earnings Call Earnings call
2025-01-14 CJS 25th Annual New Ideas for the New Year Conference Conference
2025-01-13 J.P. Morgan 43rd Annual Healthcare Conference Conference
2024-11-13 Baird 2024 Global Industrial Conference Conference
2024-11-05 Novanta, Inc. 2024 Q3 Earnings Call Earnings call

Source: https://investors.novanta.com/overview/default.aspx

Key facts CIK 1076930 CUSIP 67000B104 13F (30d) 2 filings 2 filers Visit website Investor relations